SCI
22 September 2024
Fate induction in CD8 CAR T cells through asymmetric cell division
(IF: Nature, 50.5)
Lee CS, Chen S, Berry CT, Kelly AR, Herman PJ, Oh S, O'Connor RS, Payne AS, Ellebrecht CT. Fate induction in CD8 CAR T cells through asymmetric cell division. Nature. 2024 Sep;633(8030):670-677.
Correspondence:e-mail: asp2261@cumc.columbia.edu; chell@pennmedicine.upenn.edu
Early expansion and long-term persistence predict efficacy of chimeric antigen receptor T cells (CARTs)1–7, but mechanisms governing effector versus memory CART differentiation and whether asymmetric cell division induces differential fates in human CARTs remain unclear. Here we show that target-induced proximity labelling enables isolation of first-division proximal-daughter and distal-daughter CD8 CARTs that asymmetrically distribute their surface proteome and transcriptome, resulting in divergent fates. Target-engaged CARs remain on proximal daughters, which inherit a surface proteome resembling activated-undivided CARTs, whereas the endogenous T cell receptor and CD8 enrich on distal daughters, whose surface proteome resembles resting CARTs, correlating with glycolytic and oxidative metabolism, respectively. Despite memory-precursor phenotype and in vivo longevity, distal daughters demonstrate transient potent cytolytic activity similar to proximal daughters, uncovering an effector-like state in distal daughters destined to become memory CARTs. Both partitioning of pre-existing transcripts and changes in RNA velocity contribute to asymmetry of fate-determining factors, resulting in diametrically opposed transcriptional trajectories. Independent of naive, memory or effector surface immunophenotype, proximal-daughter CARTs use core sets of transcription factors known to support proliferation and effector function. Conversely, transcription factors enriched in distal daughters restrain differentiation and promote longevity, evidenced by diminished long-term in vivo persistence and function of distal-daughter CARTs after IKZF1 disruption. These studies establish asymmetric cell division as a framework for understanding mechanisms of CART differentiation and improving therapeutic outcomes.
早期扩张和长期持续性可以预测嵌合抗原受体T细胞(CARTs)1–7的疗效,但是调控效应子与记忆型CART分化的机制,以及人类CARTs中不对称细胞分裂是否诱导了不同的命运仍不清楚。本文表明,靶标诱导的邻近标记可以分离第一次分裂的近端子代和远端子代CD8 CARTs,它们的表面蛋白质组和转录组分布不对称,因此导致不同的命运。靶标结合的CARs保留在近端子代上,它们继承了类似于活化未分裂CARTs的表面蛋白质组,而内源性T细胞受体和CD8在远端子代上富集,其表面蛋白质组类似于静息 CARTs,分别与糖酵解和氧化代谢相关。尽管具有记忆前体表型和在体内寿命,但远端子代表现出与近端子代相似的瞬时强效细胞溶解活性,揭示了注定要成为记忆CARTs的远端子代的效应器样状态。预先存在的转录物的分割和RNA速度的变化都会导致命运决定因素的不对称,从而导致截然相反的转录轨迹。无论是在体内表面免疫表型为原始型、记忆型还是效应型,近端子CARTs使用已知支持增殖和效应器功能的核心转录因子集。相反,远端子代中富集的转录因子会抑制分化并促进寿命,这体现在IKZF1破坏后远端子代CARTs的长期体内持续性和功能的减少。这些研究确立了不对称细胞分裂作为理解CART分化和改善治疗结果的框架。